aripiprazole has been researched along with Dyskinesia, Medication-Induced in 54 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 33 (61.11) | 29.6817 |
2010's | 20 (37.04) | 24.3611 |
2020's | 1 (1.85) | 2.80 |
Authors | Studies |
---|---|
Jaspers, T; Pepermans, A; Vranken, E; Wittevrongel, E | 1 |
Chan, CH; Chan, HY; Chen, YC | 1 |
Buchanan, RW; Newcomer, JW; Weiden, PJ | 1 |
Brown, R; Geddes, J; Taylor, MJ | 1 |
Chan, HY; Tan, HK; Wu, WY | 1 |
Huh, L; Lee, BJ | 1 |
Al-Jadiri, A; Azzo, S; Carbon, M; Correll, CU; Kane, JM; Kapoor, S; Saito, E; Sarkaria, T; Sheridan, E | 1 |
Flynn, A; Macaluso, M; Preskorn, S | 2 |
Patra, S | 1 |
Ahn, J; Joe, S; Lim, J; Park, C; Park, J | 1 |
Bernagie, C; Danckaerts, M; De Hert, M; Wampers, M | 1 |
Carleton, BC; Etminan, M; Procyshyn, RM; Samii, A | 1 |
Francis, A; Hameed, A; Mahgoub, Y | 1 |
Abbasian, C; Power, P | 1 |
Caykoylu, A; Deniz, O; Ekinci, O; Kuloglu, M | 1 |
Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A | 1 |
Adan-Manes, J; Garcia-Parajua, P | 1 |
Dziuba, J; Keshavan, M; Lachover, L; Manji, S; Pizzuti, A; Rajarethinam, R | 1 |
Aia, PG; Esper, CD; Factor, SA; Lungu, C; Shih, LC; Tarsy, D | 1 |
Bernardi, S; Edito, F; Meco, G; Purcaro, C; Stirpe, P; Valente, M; Vanacore, N | 1 |
Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E | 1 |
Costentin, J | 1 |
Shan, JC; Tseng, MC | 1 |
Agüera-Ortiz, L; Hurtado de Mendoza, A; Osorio, RS; Palomo, T; Ramos, I | 1 |
Agarwal, P; Griffith, A; Hall, DA; Seeberger, LC; Segro, V | 1 |
Chen, HK; Shao, CH; Wu, BJ | 1 |
Friedman, JH | 1 |
Ikawa, M; Imai, N | 1 |
Coffey, DB; John, N; Potter, PO | 1 |
Campistol, J; Darling, A; Perez-Duenas, B; Poo, P | 1 |
Goodnick, PJ; Jerry, JM | 1 |
Duggal, HS | 1 |
Cheney, EM; DeQuardo, JR; Sajbel, TA | 1 |
Winter, AS; Witschy, JK | 1 |
Baldessarini, RJ; Grant, MJ | 1 |
Bennett, N; Hirsch, J; Kafantaris, V; Saito, E | 1 |
Annable, L; Beauclair, L; Chouinard, G; Kolivakis, TT; Margolese, HC; Miller, R | 1 |
Hatchett, AD; Zacher, JL | 1 |
Raja, M | 1 |
Maytal, G; Ostacher, M; Stern, TA | 1 |
Ali, IM; Morris, HR; Wickremaratchi, M | 1 |
Clarke, K; Davies, CH; Forbes, IT; Gribble, A; Hill, M; Jones, DN; Newson, M; Reavill, C; Rourke, C; Scott, C; Westaway, J; Wood, MD | 1 |
Limosin, F | 1 |
Brahm, NC; Brown, RC; McElwain, DL | 1 |
Allen, MH; Crandall, DT; Currier, GW; Daniel, DG; Manos, G; McQuade, R; Oren, D; Pikalov, AA; Zimbroff, DL | 1 |
Gournellis, R; Lykouras, L; Rizos, E | 1 |
Evcimen, H; Evcimen, YA; Holland, J | 1 |
Kantrowitz, JT; Srihari, VH; Tek, C | 1 |
Rai, A; Spiegel, D; Urbano, M | 1 |
Lee, C; Lee, CU; Lim, HK; Pae, CU | 1 |
Eudicone, JM; Kim, E; Miller, DD; Pikalov, A | 1 |
Faruqui, RA; Zaidi, SH | 1 |
Gonidakis, F; Papadimitriou, G; Ploubidis, D | 1 |
10 review(s) available for aripiprazole and Dyskinesia, Medication-Induced
Article | Year |
---|---|
[Tardive dyskinesia in a child treated with atypical antipsychotics].
Topics: Antipsychotic Agents; Aripiprazole; Child; Dyskinesia, Drug-Induced; Humans; Male; Quetiapine Fumarate; Tardive Dyskinesia | 2020 |
Switching antipsychotic medications to reduce adverse event burden in schizophrenia: establishing evidence-based practice.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Weight; Drug Substitution; Dyskinesia, Drug-Induced; Evidence-Based Medicine; Humans; Lipids; Olanzapine; Patient Outcome Assessment; Piperazines; Psychiatric Status Rating Scales; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Schizophrenic Psychology | 2013 |
Aripiprazole alone or in combination for acute mania.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid | 2013 |
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Male; Medication Errors | 2015 |
Aripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-Analysis.
Topics: Adolescent; Age Factors; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Child; Dyskinesia, Drug-Induced; Humans; Incidence | 2016 |
[A new approach to antischizophrenic therapeutics: D2 dopamine receptor partial agonists].
Topics: Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Drug Design; Dyskinesia, Drug-Induced; History, 20th Century; Humans; Piperazines; Quinolones; Receptors, Dopamine D2; Schizophrenia | 2009 |
[Medication-related oculogyric crises: a description of four cases and a review of the literature].
Topics: Adolescent; Anticonvulsants; Antipsychotic Agents; Aripiprazole; Child; Child Behavior Disorders; Child, Preschool; Dopamine; Dopamine Antagonists; Down Syndrome; Dyskinesia, Drug-Induced; Dystonic Disorders; Electroencephalography; Epilepsy; Female; Fragile X Syndrome; Humans; Intellectual Disability; Isoxazoles; Male; Methotrimeprazine; Ocular Motility Disorders; Paliperidone Palmitate; Piperazines; Pyrimidines; Quinolones; Risperidone; Substance Withdrawal Syndrome; Translocation, Genetic; Valproic Acid | 2013 |
Aripiprazole: profile on efficacy and safety.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Brain; Cardiovascular System; Clinical Trials as Topic; Digestive System; Dyskinesia, Drug-Induced; Humans; Mental Disorders; Piperazines; Quinolones; Schizophrenia | 2002 |
Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Dyskinesia, Drug-Induced; Humans; Incidence; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles | 2005 |
[The use of atypical antipsychotics in the long-term care of schizophrenia].
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Benzodiazepines; Clozapine; Cognition Disorders; Drug Tolerance; Dyskinesia, Drug-Induced; Haloperidol; Humans; Olanzapine; Piperazines; Quinolones; Risperidone; Schizophrenia; Sulpiride; Time Factors | 2006 |
3 trial(s) available for aripiprazole and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats | 2009 |
Aripiprazole in L-dopa-induced dyskinesias: a one-year open-label pilot study.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Basal Ganglia; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mianserin; Middle Aged; Mirtazapine; Pilot Projects; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, Serotonin; Treatment Outcome | 2009 |
Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Quinolones; Schizophrenia | 2007 |
41 other study(ies) available for aripiprazole and Dyskinesia, Medication-Induced
Article | Year |
---|---|
Switching antipsychotic treatment to aripiprazole in psychotic patients with neuroleptic-induced tardive dyskinesia: a 24-week follow-up study.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Cohort Studies; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Psychotic Disorders; Schizophrenia; Taiwan; Tardive Dyskinesia | 2018 |
Suppression of antipsychotic-induced tardive dyskinesia with aripiprazole in an elderly patient with bipolar I disorder.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Quinolones; Treatment Outcome | 2014 |
Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report.
Topics: Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Dystonic Disorders; Female; Humans; Middle Aged; Piperazines; Quinolones; Treatment Outcome | 2015 |
Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics.
Topics: Adolescent; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Multivariate Analysis; New York; Olanzapine; Parkinson Disease, Secondary; Piperazines; Prospective Studies; Quetiapine Fumarate; Regression Analysis; Risperidone; Thiazoles | 2015 |
Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Tardive Dyskinesia; Young Adult | 2016 |
Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clozapine; Dyskinesia, Drug-Induced; Humans; Male; Movement Disorders; Neurologic Examination; Psychotic Disorders; Treatment Outcome; Young Adult | 2015 |
Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Clinical Trials as Topic; Clozapine; Depressive Disorder, Major; Dyskinesia, Drug-Induced; History, 20th Century; Humans; Male; United States; United States Food and Drug Administration | 2016 |
Risk of Extrapyramidal Adverse Events With Aripiprazole.
Topics: Administrative Claims, Healthcare; Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Case-Control Studies; Databases, Factual; Drug Prescriptions; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Risk; United States; Young Adult | 2016 |
Covert Dyskinesia With Aripiprazole: A Case Report.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Substance Withdrawal Syndrome | 2016 |
A case of aripiprazole and tardive dyskinesia.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Schizophrenia; Young Adult | 2009 |
Aripiprazole-induced rabbit syndrome: a case report.
Topics: Antipsychotic Agents; Aripiprazole; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones; Syndrome | 2010 |
Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
Topics: Amisulpride; Anti-Dyskinesia Agents; Antipsychotic Agents; Aripiprazole; Biperiden; Dopamine; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia, Paranoid; Schizophrenic Psychology; Sulpiride; Young Adult | 2009 |
Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Fluphenazine; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Risperidone; Schizophrenia | 2009 |
Tardive dyskinesia due to aripiprazole: report of 2 cases.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Quinolones | 2009 |
Tardive dyskinesia in a patient treated with quetiapine.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles | 2009 |
Improvement in Pisa syndrome and tardive dyskinesia following aripiprazole treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Schizophrenia; Syndrome; Treatment Outcome | 2009 |
Treatment of tardive dyskinesia with aripiprazole.
Topics: Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Mood Disorders; Piperazines; Quinolones | 2010 |
Movement disorders associated with aripiprazole use: a case series.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies; Treatment Outcome; Young Adult | 2009 |
Drug-induced Pisa syndrome associated with aripiprazole during clozapine treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Clozapine; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Piperazines; Quinolones; Schizophrenia | 2010 |
Tardive dystonia due to aripiprazole use in a neuroleptic-naive patient.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Dystonia; Female; Humans; Middle Aged; Piperazines; Quinolones | 2010 |
Efficacy of aripiprazole in sulpiride-induced tardive oromandibular dystonia.
Topics: Aged, 80 and over; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Jaw; Movement Disorders; Piperazines; Quinolones; Sulpiride | 2011 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
Aripiprazole-induced improvement in tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Chronic Disease; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Psychotic Disorders; Quinolones; Severity of Illness Index | 2003 |
Aripiprazole-associated dyskinesia.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones | 2005 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid | 2005 |
Possible improvement of neuroleptic-associated tardive dyskinesia during treatment with aripiprazole.
Topics: Antipsychotic Agents; Aripiprazole; Delusions; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Haloperidol; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome | 2005 |
Treatment of withdrawal dyskinesia.
Topics: Adolescent; Amino Acids, Branched-Chain; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Humans; Male; Neurologic Examination; Piperazines; Quinolones; Substance Withdrawal Syndrome; Treatment Outcome | 2005 |
Aripiprazole-induced movement disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Bipolar Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Quinolones; Syndrome | 2006 |
Improvement or worsening of psychotic symptoms after treatment with low doses of aripiprazole.
Topics: Adult; Aged; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Psychotic Disorders; Quinolones; Schizophrenia; Serotonin Agents; Treatment Outcome | 2007 |
Aripiprazole-related tardive dyskinesia.
Topics: Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones | 2006 |
Aripiprazole associated with severe exacerbation of Parkinson's disease.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2006 |
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties.
Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Binding, Competitive; Biotransformation; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; Male; Motor Activity; Oxidopamine; Piperazines; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Species Specificity; Transfection | 2006 |
Potential aripiprazole-mediated extrapyramidal symptoms in an adult with developmental disabilities.
Topics: Adult; Algorithms; Antipsychotic Agents; Aripiprazole; Baclofen; Basal Ganglia Diseases; Citalopram; Diphenhydramine; Drug Interactions; Dyskinesia, Drug-Induced; Humans; Hypnotics and Sedatives; Male; Mental Disorders; Oxazepam; Piperazines; Quinolones | 2007 |
Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics.
Topics: Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quetiapine Fumarate; Quinolones | 2007 |
Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
Topics: Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Quinolones; Receptors, Dopamine; Tamoxifen | 2007 |
Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
Topics: Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Male; Middle Aged; Piperazines; Quinolones; Remission Induction; Schizophrenia; Substance-Related Disorders | 2007 |
Atypical antipsychotic withdrawal dyskinesia in 4 patients with mood disorders.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Mood Disorders; Piperazines; Quinolones; Risperidone; Withholding Treatment | 2007 |
Tardive dystonic symptoms associated with aripiprazole treatment.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Comorbidity; Dyskinesia, Drug-Induced; Dystonia; Humans; Intellectual Disability; Male; Ocular Motility Disorders; Piperazines; Quinolones; Schizophrenia | 2008 |
Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Incidence; Male; Middle Aged; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Retrospective Studies; Schizophrenia; Severity of Illness Index | 2007 |
Aripiprazole is associated with early onset of Tardive Dyskinesia like presentation in a patient with ABI and psychosis.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Brain Injuries; Dyskinesia, Drug-Induced; Humans; Male; Piperazines; Psychotic Disorders; Quinolones; Treatment Outcome; Withholding Treatment | 2008 |
Aripiprazole-induced rabbit syndrome in a drug-naive schizophrenic patient.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Movement Disorders; Piperazines; Quinolones; Schizophrenia | 2008 |